Challenges and opportunities in the design of age-appropriate drug products

Polypharmacy: Misleading, but manageable

(2016) Reamer Bushardt   Clinical Interventions in Aging

Acceptance of uncoated mini-tablets in young children: results from a prospective exploratory cross-over study

(2012) Natalie Spomer et al.   ARCHIVES OF DISEASE IN CHILDHOOD

2010 FDA drug approvals

(2011) Asher Mullard   NATURE REVIEWS DRUG DISCOVERY

Development of Novel Combination Therapies

(2011) Janet Woodcock et al.   NEW ENGLAND JOURNAL OF MEDICINE

Advanced Techniques for Penetration Enhancement in Transdermal Drug Delivery System

(2011) Suryakanta Swain et al.   Current Drug Delivery

Geriatric drug therapy: Neglecting the inevitable majority

(2010) Sven Stegemann et al.   AGEING RESEARCH REVIEWS

Novel and Current Treatment Concepts Using Pulmonary Drug Delivery

(2010) Martin Hohenegger   CURRENT PHARMACEUTICAL DESIGN

The importance of new companies for drug discovery: origins of a decade of new drugs

(2010) Robert Kneller   NATURE REVIEWS DRUG DISCOVERY

Review article: dual delayed release formulation of dexlansoprazole MR, a novel approach to overcome the limitations of conventional single release proton pump inhibitor therapy

(2009) D. C. METZ et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Pharmacokinetics and drug metabolism in the elderly

(2009) Ulrich Klotz   DRUG METABOLISM REVIEWS

Accuracy of the volume-viscosity swallow test for clinical screening of oropharyngeal dysphagia and aspiration

(2008) Pere Clavé et al.   CLINICAL NUTRITION

The origins and evolution of “controlled” drug delivery systems

(2008) Allan S. Hoffman   JOURNAL OF CONTROLLED RELEASE